Deregulation of the phosphatase, PP2A is a common event in breast cancer, predicting sensitivity to FTY720

Deregulation of the phosphatase, PP2A is a common event in breast cancer, predicting sensitivity to FTY720

Bibliographic Details
Main Authors:	Baldacchino, Shawn, Saliba, Christian, Petroni, Vanessa, Fenech, Anthony G, Borg, Nigel, Grech, Godfrey
Format:	Online
Language:	English
Published:	BioMed Central 2014
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3913630/

Similar Items

FTY720 attenuates excitotoxicity and neuroinflammation
by: Cipriani, Raffaela, et al.
Published: (2015)

Predictive markers in cancer patient diagnosis, classification and prediction of therapy outcome using leukaemia as a model
by: Grech, Godfrey, et al.
Published: (2014)

The antineoplastic properties of FTY720: Evidence for the repurposing of fingolimod
by: Patmanathan, S.N., et al.
Published: (2015)

The emerging role of FTY720 (Fingolimod) in cancer treatment
by: White, Christopher, et al.
Published: (2016)

The antineoplastic properties of FTY720: evidence for the repurposing of fingolimod
by: Patmanathan, Sathya Narayanan, et al.
Published: (2015)

Preclinical Metabolism, Pharmacokinetics and In Vivo Analysis of New Blood-Brain-Barrier Penetrant Fingolimod Analogues: FTY720-C2 and FTY720-Mitoxy
by: Enoru, Julius O., et al.
Published: (2016)

Fingolimod (Gileyna, FTY720): Innovative treatment for multiple sclerosis
by: Pinki,, et al.
Published: (2011)

The Immunosuppressant FTY720 (Fingolimod) enhances Glycosaminoglycan depletion in articular cartilage
by: Stradner, Martin H, et al.
Published: (2011)

Lymphocyte Modulation with FTY720 Improves Hemorrhagic Shock Survival in Swine
by: Hawksworth, Jason S., et al.
Published: (2012)

Fingolimod (FTY720): First approved oral therapy for multiple sclerosis
by: Sharma, Sushil, et al.
Published: (2011)

FTY720 in multiple sclerosis: the emerging evidence of its therapeutic value
by: Thomson, Andrew
Published: (2006)

Dual effects of daily FTY720 on human astrocytes in vitro: relevance for neuroinflammation
by: Wu, Celina, et al.
Published: (2013)

Fingolimod (FTY720) Stimulates Ca2+/Calcineurin Signaling in Fission Yeast
by: Hagihara, Kanako, et al.
Published: (2013)

Metformin and FTY720 Synergistically Induce Apoptosis in Multiple Myeloma Cells
by: Yi Zhao, et al.
Published: (2018-07-01)

The effect of the sphingosine‐1‐phosphate analogue FTY720 on atrioventricular nodal tissue
by: Egom, Emmanuel E., et al.
Published: (2015)

FTY720 inhibited proinflammatory cytokine release and osteoclastogenesis induced by Aggregatibacter actinomycetemcomitans
by: Yu, Hong, et al.
Published: (2015)

FTY720 (Fingolimod) sensitizes hepatocellular carcinoma cells to sorafenib-mediated cytotoxicity
by: Ahmed, Dilruba, et al.
Published: (2015)

Development and Effects of FTY720 Ophthalmic Solution on Corneal Allograft Survival
by: Liu, Zhaochuan, et al.
Published: (2015)

Antinociceptive activity of the S1P-receptor agonist FTY720
by: Coste, Ovidiu, et al.
Published: (2008)

FTY720 (fingolimod) modulates the severity of viral-induced encephalomyelitis and demyelination
by: Blanc, Caroline A, et al.
Published: (2014)

Protective role of fingolimod (FTY720) in rats subjected to subarachnoid hemorrhage
by: Xu, Hao-Liang, et al.
Published: (2015)

The phosphorylated form of FTY720 activates PP2A, represses inflammation and is devoid of S1P agonism in A549 lung epithelial cells
by: Rahman, Md. Mostafizur, et al.
Published: (2016)

Disparate In Vivo Efficacy of FTY720 in Xenograft Models of Philadelphia Positive and Negative B-lineage Acute Lymphoblastic Leukemia
by: Wallington-Beddoe, Craig T., et al.
Published: (2012)

Correction: Disparate In Vivo Efficacy of FTY720 in Xenograft Models of Philadelphia Positive and Negative B-lineage Acute Lymphoblastic Leukemia
by: Wallington-Beddoe, Craig T., et al.
Published: (2012)

Sphingosine analogue drug FTY720 targets I2PP2A/SET and mediates lung tumour suppression via activation of PP2A-RIPK1-dependent necroptosis
by: Saddoughi, Sahar A, et al.
Published: (2013)

CC Chemokine Receptor 7–dependent and –independent Pathways for Lymphocyte Homing: Modulation by FTY720
by: Henning, Golo, et al.
Published: (2001)

FTY720 Suppresses Liver Tumor Metastasis by Reducing the Population of Circulating Endothelial Progenitor Cells
by: Li, Chang Xian, et al.
Published: (2012)

Topographical and Biological Evidence Revealed FTY720-Mediated Anergy-Polarization of Mouse Bone Marrow-Derived Dendritic Cells In Vitro
by: Zeng, Xiangfeng, et al.
Published: (2012)

Effect of FTY720 on Some Physiological Indexes of Non-Obese Diabetic (NOD) Mice
by: Chen, Xiaoqiang, et al.
Published: (2012)

Treatment with the immunomodulator FTY720 does not promote spontaneous bacterial infections after experimental stroke in mice
by: Pfeilschifter, Waltraud, et al.
Published: (2011)

FTY720 Reduces Post-Ischemic Brain Lymphocyte Influx but Does Not Improve Outcome in Permanent Murine Cerebral Ischemia
by: Liesz, Arthur, et al.
Published: (2011)

Topical application of FTY720 and cyclosporin A prolong corneal graft survival in mice
by: Liu, Yong, et al.
Published: (2012)

The imbalance between Treg and Th17 cells caused by FTY720 treatment in skin allograft rejection
by: Commodaro, Alessandra Gonçalves, et al.
Published: (2012)

FTY720 Protects Cardiac Microvessels of Diabetes: A Critical Role of S1P1/3 in Diabetic Heart Disease
by: Yin, Zhiyong, et al.
Published: (2012)

FTY720/Fingolimod, a Sphingosine Analogue, Reduces Amyloid-β Production in Neurons
by: Takasugi, Nobumasa, et al.
Published: (2013)

Antiobesity activity of a sphingosine 1-phosphate analogue FTY720 observed in adipocytes and obese mouse model
by: Moon, Myung-Hee, et al.
Published: (2012)

FTY720 Treatment in the Convalescence Period Improves Functional Recovery and Reduces Reactive Astrogliosis in Photothrombotic Stroke
by: Brunkhorst, Robert, et al.
Published: (2013)

FTY720 attenuates accumulation of EMAP-II+ and MHC-II+ monocytes in early lesions of rat traumatic brain injury
by: Zhang, Zhiyuan, et al.
Published: (2007)

Inhibition of basal-like breast cancer growth by FTY720 in combination with epidermal growth factor receptor kinase blockade
by: Janet L. Martin, et al.
Published: (2017-08-01)

Differential effects of FTY720 on the B cell compartment in a mouse model of multiple sclerosis
by: Kathrin Bail, et al.
Published: (2017-07-01)